Low Incidence of Candidaemia among Neutropenic Patients Treated for Haematological Diseases

References

• Nguyen MH, Peacock JE Jr, Morris AJ, Tanner DC, Nguyen ML, Snydman DR, Wagener MM, Rinaldi MG, Yu VL. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996; 100: 617–23.
   PubMed Web of Science ®Google Scholar
• Voss A, Kluytmans JA, Koeleman JG, Spanjaard L, Vandenbroucke-Grauls CM, Verbrugh HA, Vos MC, Weerink AY, Hoogkamp-Korstanje JA, Meis JF. Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals. Eur J Clin Microbiol Infect Dis 1996; 15: 909–12.
   Google Scholar
• Voss A, le Noble JL, Verduyn Lunel FM, Foudraine NA, Meis JF. Candidemia in intensive care unit patients: risk factors for mortality. Infection 1997; 25: 8–11.
   PubMed Web of Science ®Google Scholar
• Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997; 24: 1122–8.
   Google Scholar
• Bruun B, Westh H, Stenderup J. Fungemia: an increasing problem in a Danish university hospital 1989 to 1994. J Clin Microbiol Infect 1995; 1: 124–6.
   Google Scholar
• Debusk CH, Daoud R, Thirumoorthi MC, Wilson FM, Khatib R. Candidemia: current epidemiologic characteristics and a long-term follow-up of the survivors. Scand J Infect Dis 1994; 26: 697–703.
   Google Scholar
• Simmons BP, Gelfand MS, Kritchevsky SB, Greene W, Chow S. Decrease in candidemia rates associated with empiric use of amphotericin B and fluconazole for nosocomial fever of unknown origin. Infect Dis Clin Pract 1997; 6: 177–81.
   Google Scholar
• Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995; 20: 1526–30.
   PubMed Web of Science ®Google Scholar
• Giamarellou H, Antoniadou A. Epidemiology, diagnosis, and therapy of fungal infections in surgery. Infect Contr Hosp Epidemiol 1996; 17: 558–64.
   PubMed Web of Science ®Google Scholar
• Kralovicova K, Spanik S, Oravcova E, Mrazova M, Morova E, Gulikova V, Kukuckova E, Koren P, Pichna P, Nogova J, Kunova A, Trupl J, Krcmery V. Fungemia in cancer patients undergoing chemotherapy versus surgery – risk factors, etiology and outcome. Scand J Infect Dis 1997; 29: 301–4.
   Google Scholar
• Chubachi A, Miura I, Ohshima A, Nishinari T, Nimura T, Niitsu H, Miura AB. Risk factors for hepatosplenic abscesses in patients with acute leukemia receiving empiric azole treatment. Am J Med Sci 1994; 308: 309–12.
   Google Scholar
• Cole GT, Halawa AA, Anaissie EJ. The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. Clin Infect Dis 1996; 22 (Suppl 2): S73–88.
   Google Scholar
• Bernhardt H, Knoke M. Mycological aspects of gastrointestinal microflora. Scand J Gastroenterol Suppl 1997; 222: 102–6.
   PubMedGoogle Scholar
• Barnett JA, Payne RW, Yarrow D. Yeasts: characteristics and identification. Cambridge: Cambridge University Press, 1990.
   Google Scholar
• De Hoog GS, Guarro J. Atlas of clinical fungi. Baarn and Delft: Centraalbureau voor Schimmelcultures, 1995.
   Google Scholar
• Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia. A matched case–control study. Arch Intern Med 1989; 149: 2349–53.
   PubMedGoogle Scholar
• Voss A, Hollis RJ, Pfaller MA, Wenzel RP, Doebbeling BN. Investigation of the sequence of colonization and candidemia in neutropenic patients. J Clin Microbiol 1994; 32: 975–80.
   Google Scholar
• Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220: 751–8.
   Google Scholar
• Reagan DR, Pfaller MA, Hollis RJ, Wenzel RP. Characterization of the sequence of colonization of nosocomial candidemia using DNA fingerprinting and a DNA probe. J Clin Microbiol 1990; 28: 2733–8.
   PubMed Web of Science ®Google Scholar
• Martino P, Girmenia C, Venditti M, Micozzi A, Santilli S, Burgio VL, Mandelli F. Candida colonization and systemic infection in neutropenic patients. Cancer 1989; 64: 2030–4.
   Google Scholar
• Guiot HFL, Fibbe WE, van’t Wout JW. Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. Clin Infect Dis 1994; 18: 525–32.
   Google Scholar
• Bow EJ, Loewen R, Cheang MS, Schacter B. Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of antileukemic regimen. Clin Infect Dis 1995; 21: 361–9.
   PubMed Web of Science ®Google Scholar
• Denning DW, Evans EGV, Kibbler CC, Richardson MD, Roberts MM, Rogers TR, Warnock DW, Warren RE. Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. Eur J Clin Microbiol Infect Dis 1997; 16: 424–36.
   PubMed Web of Science ®Google Scholar
• Creger RJ, Weeman KE, Jacobs MR, Morrissey A, Parker P, Fox RM, Lazarus HM. Lack of utility of the lysis–centrifugation blood culture method for detection of fungemia in immunocompromised cancer patients. J Clin Microbiol 1998; 36: 290–3.
   Google Scholar
• Lyon R, Woods G. Comparison of the BacT/Alert and Isolator blood culture systems for recovery of fungi. Am J Clin Pathol 1995; 103: 660–2.
   PubMed Web of Science ®Google Scholar
• Weinstein MP, Mirrett S, Reimer LG, Wilson ML, Smith-Elekes S, Chirard CR, Reller LB. Controlled evaluation of BacT/Alert standard aerobic and FAN aerobic blood culture bottles for detection of bacteremia and fungemia. J Clin Microbiol 1995; 33: 978–81.
   Google Scholar
• Björkholm M. Prophylaxis of fungal infections in neutropenic patients. Meeting of the Expert Sessions of the Second EHA, 1996; 14–9.
   Google Scholar
• Gøtzsche PC, Johansen HK. Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated neutropenia. BMJ 1997; 314: 1238–44.
   Google Scholar
• Van Delden C, Lew DP, Chapius B, Rohner P, Hirschel B. Antifungal prophylaxis in severely neutropenic patients: how much fluconazole is necessary? J Clin Microbiol Infect 1995; 1: 24–30.
   Google Scholar
• Uzun O, Anaissie EJ. Problems and controversies in the management of hematogenous candidiasis. Clin Infect Dis 1996; 22 (Suppl 2): S95–101.
   PubMed Web of Science ®Google Scholar
• Philpott-Howard JN, Wade JJ, Mufti GJ, Brammer KW, Ehninger G, for the Multicentre Study Group. Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. J Antimicrob Chemother 1993; 31: 973–84.
   Google Scholar
• Occhipinti DJ, Gubbins PO, Schreckenberger P, Danziger LH. Frequency, pathogenicity and microbiologic outcome of non-Candida albicans candiduria. Eur J Clin Microbiol Infect Dis 1994; 13: 459–67.
   PubMedGoogle Scholar
• EORTC International Antimicrobial Therapy Cooperative Group. Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med 1989; 86: 668–72.
   Google Scholar
• Denning DW. Aspergillosis: diagnosis and treatment. Int J Antimicrob Agents 1996; 6: 161–8.
   PubMedGoogle Scholar
• Richet HM, Andremont A, Tancrede C, Pico JL, Jarvis WR. Risk factors for candidemia in patients with acute lymphocytic leukemia. Rev Infect Dis 1991; 13: 211–5.
   Google Scholar
• Bergmann OJ, Mogensen SC, Ellermann-Eriksen S, Ellegaard J. Acyclovir prophylaxis and fever during remission–induction therapy of patients with acute myeloid leukemia: a randomized, double-blind, placebo-controlled trial. J Clin Oncol 1997; 15: 2269–74.
   Google Scholar